May 23, 2023 07:00 PM Eastern Daylight Time HAWTHORNE, N.Y.--( BUSINESS WIRE )--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2023. Quarter ended March 31, 2023* Highlights ─ compared to
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 24, 2023-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2022 . Quarter ended December 31, 2022 * Highlights ─ compared to December 31,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2022 . Quarter ended September 30, 2022 * Highlights ─ compared to September
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jul. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2022 . Quarter ended June 30, 2022 * Highlights ─ compared to June 30, 2021 Net sales increased
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 26, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2022 . Quarter ended March 31, 2022 Highlights ─ compared to March 31, 2021 The quarter
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2021 . Quarter ended December 31, 2021 Highlights ─ compared to December 31,